154 related articles for article (PubMed ID: 14745558)
1. Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).
Jung M; Grunberg S; Timblin C; Buder-Hoffman S; Vacek P; Taatjes DJ; Mossman BT
Histochem Cell Biol; 2004 Feb; 121(2):115-21. PubMed ID: 14745558
[TBL] [Abstract][Full Text] [Related]
2. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
Budman DR; Calabro A; Wang LG; Liu XM; Stiel L; Adams LM; Kreis W
Cancer Invest; 2000; 18(8):695-701. PubMed ID: 11107439
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
[TBL] [Abstract][Full Text] [Related]
4. [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].
Qian XP; Liu BR; Wan L; Hu J; Zhu LJ; Yu LX
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):253-7. PubMed ID: 20510073
[TBL] [Abstract][Full Text] [Related]
5. [Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro].
Liu JJ; Chen GY; Wang M; Yang ZY; Hong X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):743-7. PubMed ID: 21163063
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells.
Liu XM; Wang LG; Kreis W; Budman DR; Adams LM
Br J Cancer; 2001 Nov; 85(9):1403-11. PubMed ID: 11720482
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells.
Knick VC; Eberwein DJ; Miller CG
J Natl Cancer Inst; 1995 Jul; 87(14):1072-7. PubMed ID: 7616599
[TBL] [Abstract][Full Text] [Related]
8. [Effect of sCD40L combined with vinorelbine on lung adenocarcinoma cell A549].
Liu S; Chen B; Li Y; Zhao W; Wu J
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):686-90. PubMed ID: 20673484
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
Menendez JA; Colomer R; Lupu R
Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line.
Oyaizu H; Adachi Y; Okumura T; Okigaki M; Oyaizu N; Taketani S; Ikebukuro K; Fukuhara S; Ikehara S
Oncol Rep; 2001; 8(4):825-9. PubMed ID: 11410792
[TBL] [Abstract][Full Text] [Related]
11. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.
Zuco V; De Cesare M; Cincinelli R; Nannei R; Pisano C; Zaffaroni N; Zunino F
PLoS One; 2011; 6(12):e29085. PubMed ID: 22194993
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells.
Chiu WH; Chen HH; Chang JY; Luo SJ; Li CL; Chen CL; Su WC; Lin CF
Cancer Lett; 2014 Jul; 349(2):144-51. PubMed ID: 24735752
[TBL] [Abstract][Full Text] [Related]
15. Effects of monoclonal antibodies against human stathmin combined with paclitaxel on proliferation of the QG-56 human lung carcinoma cell line.
Yuan SF; Chen WJ; Zhu LJ; Zheng WE; Chen H; Xiong JP
Asian Pac J Cancer Prev; 2012; 13(6):2967-71. PubMed ID: 22938491
[TBL] [Abstract][Full Text] [Related]
16. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
17. An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.
Chiu WH; Su WC; Li CL; Chen CL; Lin CF
Oncotarget; 2015 Aug; 6(24):20513-24. PubMed ID: 26001295
[TBL] [Abstract][Full Text] [Related]
18. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
19. Proapoptotic lipid nanovesicles: synergism with paclitaxel in human lung adenocarcinoma A549 cells.
Joshi N; Shanmugam T; Kaviratna A; Banerjee R
J Control Release; 2011 Dec; 156(3):413-20. PubMed ID: 21807043
[TBL] [Abstract][Full Text] [Related]
20. [Nimotuzumab significantly enhances chemosensitivity of
PC9 human lung adenocarcinoma cells to paclitaxel in vitro].
Xiao Y; Cao B; Liang L
Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):98-103. PubMed ID: 25676404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
